Loading clinical trials...
Loading clinical trials...
This first-in-human study will evaluate the safety and tolerability of ADX-626 in healthy participants. The study will also look at how ADX-626 interacts with the human body (the pharmacokinetics and ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
ADARx Pharmaceuticals, Inc.
NCT07483606 · Healthy Adult Participants, Toxic Chemicals, and more
NCT06342713 · Healthy Participants, Healthy Subjects, and more
NCT07457736 · Healthy Adult Participants
NCT07335419 · Healthy Adult Participants
NCT07544472 · Healthy Adult Participants
Richmond Pharmacology
London
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions